Triple-negative breast cancer, one of the deadliest and most aggressive forms of breast cancer, spreads quickly, is resistant to many chemotherapies and is likely to reoccur even after a seemingly successful round of therapies. The cause for the later is the resiliency of a subset of cancer cells called cancer…...
The effectiveness of certain chemotherapy drugs may be reduced by fat cells. This groundbreaking recent discovery was made according to a recent study published in November 2017 in Molecular Cancer Research, a journal of the American Association for Cancer Research. Obesity has long been associated with a higher risk of…...
A 2017 epidemiological study published in Frontiers in Oncology suggests that a diet rich in antioxidants like carotenoids and vitamin C can help to prevent breast cancer and lung cancer. Antioxidants have had their fair share of press in recent years and numerous studies have been done trying to pinpoint their…...
January is Cervical Cancer Awareness Month, and the National Foundation for Cancer Research (NFCR) joins others in raising awareness of and informing of steps toward preventing the disease—one of the most detectable and treatable cancers, if vigilance is observed. Here is information and a set of best practices. Risk Factors:…...
The mental status of cancer survivors can be fragile and destabilized. Psycho-social complications often arise, such as fear of recurrent illness, financial hardship, anxiety, difficulty handling the end of treatment, fatigue, lasting “brain fog”, broken relationships and even post-traumatic stress disorder. In order to navigate this myriad of challenging issues…...
It is estimated that by the year 2030, deaths due to cancer will drop dramatically and life expectancy after diagnosis will have significantly increased. Whereas this is encouraging news and proof positive that the practice of oncology and the drugs used to treat cancer have become progressively more effective, there…...
Cancer researchers at the Thomas Jefferson University in Philadelphia have zeroed in on a specific type of gene loss that sets off large-scale genetic changes that could make prostate cancer both resistant to treatment and more likely to spread. The discovery concerns the retinoblastoma (RB) susceptibility gene, the first “gatekeeper…...
Free Cancer Screening Guidelines
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
5515 Security Lane, Suite 1105 Rockville, MD 20852
